Clinical Trial Update: Prospective, Long-term Evaluation of the SAPIEN 3 Ultra RESILIA Valve

View source ↗

Summary

This clinical trial update reports a prospective, long-term evaluation of the SAPIEN 3 Ultra RESILIA transcatheter heart valve, with the study currently not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Regurgitation
• Aortic Stenosis
• Degenerative Valvular Disease

Drugs mentioned

• SAPIEN 3 Ultra RESILIA Valve

Snippet

Sponsor: Institut für Pharmakologie und Präventive Medizin | Conditions: Transcatheter Aortic Valve Replacement (TAVR), Aortic-Stenosis | Status: NOT_YET_RECRUITING